Expertise in
27
conditions

Dr. Grant M. Clark

Radiation Oncology
Thompson Cancer Survival Center
1915 White Ave, 
Knoxville, TN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
27
conditions
Thompson Cancer Survival Center
1915 White Ave, 
Knoxville, TN 

Overview

Grant Clark is a Radiation Oncologist practicing medicine in Knoxville, Tennessee.

Dr. Clark is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Astrocytoma.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 7 clinical trials. Dr. Clark is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in TN

Hospital Affiliations

Fort Sanders Regional Medical Center
Cumberland Medical Center
Methodist Medical Center Of Oak Ridge
Morristown Hamblen Hospital Association
Parkwest Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Thompson Cancer Survival Center
1915 White Ave, Knoxville, TN 37916

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Enrollment Status: Recruiting
Publish Date: April 17, 2026
Intervention Type: Other, Device
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
View 6 Less Clinical Trials

8 Total Publications

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: 5-Year Toxicity and Biochemical Recurrence Results From a Prospective Trial.
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: 5-Year Toxicity and Biochemical Recurrence Results From a Prospective Trial.
Journal: Practical radiation oncology
Published: March 26, 2023
Similar Doctors
Expertise in
18
conditions
Dr. Nilesh S. Patel
Radiation Oncology
Expertise in
18
conditions
Dr. Nilesh S. Patel
Radiation Oncology
Referral may be required

Tennessee Cancer Specialists

7551 Dannaher Dr, 
Powell, TN 
 (7.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nilesh Patel is a Radiation Oncologist practicing medicine in Powell, Tennessee. Dr. Patel is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Primitive Neuroectodermal Tumor (PNET). Dr. Patel is currently accepting new patients.

Expertise in
18
conditions
Dr. Joseph T. Meyer
Radiation Oncology
Expertise in
18
conditions
Dr. Joseph T. Meyer
Radiation Oncology
Referral may be required

The Thompson Cancer Survival Center

9711 Sherrill Blvd, 
Knoxville, TN 
 (9.9 miles away)
865-373-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Meyer is a Radiation Oncologist practicing medicine in Knoxville, Tennessee. Dr. Meyer is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Pleuropulmonary Blastoma, Lung Cancer, and Intraductal Papilloma. Dr. Meyer is currently accepting new patients.

Expertise in
9
conditions
Dr. Allen G. Meek
Radiation Oncology
Expertise in
9
conditions
Dr. Allen G. Meek
Radiation Oncology
Referral may be required

Proton Therapy Center LLC

6450 Provision Cares Way, 
Knoxville, TN 
 (5.0 miles away)
865-862-1600
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Allen Meek is a Radiation Oncologist practicing medicine in Knoxville, Tennessee. Dr. Meek is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Familial Prostate Cancer, Prostate Cancer, and Familial Pancreatic Cancer. Dr. Meek is currently accepting new patients.

Frequently Asked Questions about Dr. Grant M. Clark

How do I make an appointment with Dr. Grant M. Clark?

You can book an appointment with Dr. Grant M. Clark by calling their office at 865-541-1155. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Grant M. Clark a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Grant M. Clark is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Grant M. Clark specialize in?

While Dr. Grant M. Clark is a Radiation Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Grant M. Clark participate in research or clinical trials?

Yes. Dr. Grant M. Clark has published 8 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Grant M. Clark's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Grant M. Clark accept my insurance?

Dr. Grant M. Clark accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 865-541-1155 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Clark's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 17 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile